This review examines the effect of targeting the insulin‐like growth factor 1 receptor (IGF‐IR) in human cancers. The results are disappointing. The causes for the failure are discussed, as well as the possible use of the IGF‐IR as a secondary target. J. Cell. Physiol. 228: 675–679, 2013.
No takes yet. Share an insight, caveat, or question.
Renato Baserga (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: